Cargando…
Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
Autores principales: | White, Rhonda R., Dyer, Molly C., Hosseinipour, Mina C., Delany‐Moretlwe, Sinead |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339002/ https://www.ncbi.nlm.nih.gov/pubmed/37439067 http://dx.doi.org/10.1002/jia2.26120 |
Ejemplares similares
-
PrEP: controversy, agency and ownership
por: Cairns, Gus P, et al.
Publicado: (2016) -
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023) -
Were we prepared for PrEP? Five years of implementation
por: Weinstein, Michael, et al.
Publicado: (2017) -
Pharmacy delivery to expand the reach of PrEP in Africa
por: Ortblad, Katrina F, et al.
Publicado: (2020) -
PrEP implementation research in Africa: what is new?
por: Cowan, Frances M, et al.
Publicado: (2016)